These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

886 related items for PubMed ID: 9420491

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Acute myocardial infarction and combined oral contraceptives: results of an international multicentre case-control study. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.
    Lancet; 1997 Apr 26; 349(9060):1202-9. PubMed ID: 9130941
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Estimates of the risk of cardiovascular death attributable to low-dose oral contraceptives in the United States.
    Schwingl PJ, Ory HW, Visness CM.
    Am J Obstet Gynecol; 1999 Jan 26; 180(1 Pt 1):241-9. PubMed ID: 9914611
    [Abstract] [Full Text] [Related]

  • 25. Risk factors for fatal venous thromboembolism in young women: a case-control study.
    Thorogood M, Mann J, Murphy M, Vessey M.
    Int J Epidemiol; 1992 Feb 26; 21(1):48-52. PubMed ID: 1544757
    [Abstract] [Full Text] [Related]

  • 26. The influence of thrombotic risk factors when oral contraceptives are prescribed. A control-only study.
    Lidegaard O.
    Acta Obstet Gynecol Scand; 1997 Mar 26; 76(3):252-60. PubMed ID: 9093141
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Oral contraceptives and venous thromboembolism: a case-control study designed to minimize detection bias.
    Realini JP, Encarnacion CE, Chintapalli KN, Rees CR.
    J Am Board Fam Pract; 1997 Mar 26; 10(5):315-21. PubMed ID: 9297655
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Oral contraceptives and vascular disease.
    Sartwell PE, Stolley PD.
    Epidemiol Rev; 1982 Mar 26; 4():95-109. PubMed ID: 6754411
    [Abstract] [Full Text] [Related]

  • 33. Rebuilding confidence in oral contraceptives: a new imperative in family planning.
    Spitzer WO.
    Br J Clin Pharmacol; 1996 May 26; 41(5):359-63. PubMed ID: 8735675
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Blood pressure in women using oral contraceptives: results from the Health Survey for England 1994.
    Dong W, Colhoun HM, Poulter NR.
    J Hypertens; 1997 Oct 26; 15(10):1063-8. PubMed ID: 9350579
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Oral contraceptives: APF takes a position].
    Sex Planeam Fam; 1995 Oct 26; (7):17-8. PubMed ID: 12179267
    [Abstract] [Full Text] [Related]

  • 38. The risk of venous thromboembolism in users of postcoital contraceptive pills.
    Vasilakis C, Jick SS, Jick H.
    Contraception; 1999 Feb 26; 59(2):79-83. PubMed ID: 10361621
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Oral contraceptive use before and after the latest pill scare in The Netherlands. Changes in oral contraceptive use and how users change.
    de Vries CS, van den Berg PB, de Jong-van den Berg LT.
    Contraception; 1998 Apr 26; 57(4):247-9. PubMed ID: 9649916
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 45.